putranjivain A

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 02/01/2014 - "Putranjivain A (PJA), member of ellagitannin, is known to possess beneficial effects including anti-cancer and anti-viral activities. "
2.	Inflammation (Inflammations) 02/01/2014 - "Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation."
3.	Infections 04/01/2004 - "It was shown that putranjivain A exhibited antiviral activity with an IC50 of 7.9 +/- 1.2 micro M using the XTT assay, with the IC50 value increasing with increasing multiplicity of infection. "
4.	Adenocarcinoma 05/15/2006 - "Putranjivain A, isolated from the whole plant of Euphorbia jolkini Bioss (Euphorbiaceae), was investigated for its antiproliferative activity in human breast adenocarcinoma MCF-7 cells. " 05/15/2006 - "Putranjivain A from Euphorbia jolkini inhibits proliferation of human breast adenocarcinoma MCF-7 cells via blocking cell cycle progression and inducing apoptosis."

1.	Antiviral Agents (Antivirals)
2.	ellagitannin